FDA Approves Myobloc (rimabotulinumtoxinB) Injection for Chronic Sialorrhea

Article Link: FDA Approves Myobloc (rimabotulinumtoxinB) Injection for Chronic Sialorrhea

LOUISVILLE, Ky., Aug. 26, 2019 /PRNewswire/ — US WorldMeds, LLC announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application (sBLA) for Myobloc (rimabotulinumtoxinB) injection for the…

Source: FDA New Drug Approvals